Advertisement
Age

Risk Factors ID’d for Diffuse Large B-Cell Lymphoma Mortality

0
In older patients, risk factors include advanced age, DLBCL stage, Charlson Comorbidity Index
Artificial intelligence software can predict prognosis in epithelial ovarian cancer above established prognostic methods

Artificial Intelligence Predicts Survival in Epithelial Ovarian Cancer

0
Radiomic Prognostic Vector IDs patients with median overall survival of less than two years
Growth in hospital prices and payments outpaced growth in physician prices and payments from 2007 through 2014

Hospital Prices Growing Faster Than Physician Prices

0
Efforts to reduce health care spending should focus on hospital prices
People with a wide variety of chronic diseases are less physically active than individuals without chronic diseases

Physical Activity Down Across Chronic Disease Subgroups

0
Mental health disorders tied to lowest moderate activity; those with CVD have lowest vigorous activity
p

p, p’-DDT Exposure Linked to Breast Cancer Through Age 54

0
Risk for breast cancer varies based on timing of first exposure, age at diagnosis
Dialysis and kidney transplant patients have more than a 2.5-fold increased risk for cancer death

Cancer Death Risk Up for Kidney Transplant, Dialysis Patients

0
Risk mainly due to preexisting cancers in dialysis patients, de novo cancers in transplant recipients
Neoadjuvant administration of programmed cell death protein 1 blockade seems to enhance local and systemic antitumor immune response in glioblastoma

Neoadjuvant PD-1 Blockade Seems Effective in Glioblastoma

0
Neoadjuvant pembrolizumab with adjuvant therapy after surgery linked to extended overall survival
For children with acute lymphoblastic leukemia

Obesity Linked to Adverse Events in Children With Leukemia

0
Obesity ups risk for treatment-requiring hypertension, insulin-requiring hyperglycemia
For patients with multiple myeloma

HRQoL Scores Decrease With Treatment Line in Multiple Myeloma

0
Relatively high scores seen for patients with multiple myeloma in first treatment-free interval
Physicians treating certain cancers who consistently receive payments from a cancer drug's manufacturer are more likely to prescribe that drug instead of other treatments

Drug Company Payments Over Time May Influence Rx Practices

0
Payment consistency, high amount, compensation payments tied to cancer drug prescribing practices